Alfred Zippelius Selected Research

Hyponatremia

5/2022

Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfred Zippelius Research Topics

Disease

73	Neoplasms (Cancer) 01/2022 - 01/2002
24	Melanoma (Melanoma, Malignant) 11/2019 - 07/2002
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2013
7	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2004
5	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2004
4	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2015
4	Pneumonia (Pneumonitis) 01/2018 - 12/2015
2	Disease Progression 01/2022 - 10/2014
2	Tertiary Lymphoid Structures 01/2021 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2018
2	Carcinogenesis 10/2020 - 10/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 10/2019
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Adenocarcinoma 01/2017 - 05/2016
2	Inflammation (Inflammations) 01/2016 - 11/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2013
1	Hyponatremia 05/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 07/2019 - 01/2002
12	AntibodiesIBA 01/2022 - 10/2002
11	Immune Checkpoint InhibitorsIBA 08/2020 - 01/2016
10	Peptides (Polypeptides)IBA 12/2018 - 07/2002
9	Proteins (Proteins, Gene)FDA Link 03/2021 - 09/2004
8	MART-1 AntigenIBA 10/2010 - 07/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 10/2002
6	LigandsIBA 01/2020 - 10/2010
6	Messenger RNA (mRNA)IBA 12/2019 - 06/2007
6	VaccinesIBA 01/2018 - 01/2002
5	Pharmaceutical PreparationsIBA 01/2021 - 11/2015
5	CytokinesIBA 01/2020 - 02/2016
5	IpilimumabIBA 01/2016 - 01/2015
4	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 08/2014
4	NivolumabIBA 07/2019 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2020
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2022 - 11/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2015
3	EpitopesIBA 03/2009 - 07/2002
3	Differentiation AntigensIBA 02/2007 - 04/2004
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 09/2015
2	Interleukin-2 (IL2)IBA 03/2021 - 10/2010
2	AutoantigensIBA 01/2021 - 05/2003
2	InterferonsIBA 01/2021 - 01/2019
2	Antisense OligonucleotidesIBA 01/2020 - 12/2019
2	Bispecific AntibodiesIBA 12/2019 - 02/2016
2	Blocking AntibodiesIBA 11/2019 - 03/2015
2	Monoclonal AntibodiesIBA 08/2019 - 11/2018
2	carbonic anhydrase XIIIBA 08/2019 - 12/2015
2	pembrolizumabIBA 07/2019 - 01/2015
2	SurvivinIBA 05/2019 - 01/2019
2	Uncoupling Protein 2IBA 04/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 09/2017
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 11/2015
2	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 04/2004
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 01/2016
2	PlatinumIBA 01/2018 - 01/2017
2	Pemetrexed (MTA)FDA Link 01/2017 - 09/2015
2	Bevacizumab (Avastin)FDA Link 01/2017 - 09/2015
2	Drug CombinationsIBA 01/2016 - 09/2015
2	VemurafenibIBA 01/2015 - 05/2013
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2010 - 05/2004
2	HLA-A*02:01 antigenIBA 12/2006 - 02/2003
1	Alkaline PhosphataseIBA 05/2022
1	AlbuminsIBA 05/2022
1	MagnesiumIBA 01/2022
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2022
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 10/2021
1	durvalumabIBA 10/2021
1	InterleukinsIBA 03/2021
1	NPI 2358IBA 01/2021
1	CarbohydratesIBA 10/2020
1	LectinsIBA 10/2020
1	HexosaminesIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2020
1	SelectinsIBA 10/2020
1	Polysaccharides (Glycans)IBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Interleukin-13IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2020
1	locked nucleic acidIBA 01/2020
1	KynurenineIBA 01/2020
1	Angiopoietin-2IBA 01/2020
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 01/2020
1	cibisatamabIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	Adenosine (Adenocard)FDA LinkGeneric 12/2019

Therapy/Procedure

30	Immunotherapy 01/2022 - 01/2002
28	Therapeutics 03/2021 - 08/2003
7	Drug Therapy (Chemotherapy) 10/2021 - 01/2013
6	Radiotherapy 01/2019 - 01/2014
3	Neoadjuvant Therapy 10/2021 - 09/2015